Riskpilot← Back to searchSign inGet full accessToxoTech AB
ABActiveOrg 5592341456Sergeantgränd 16Research and experimental development on natural sciences and engineering · NACE 7210Est. 20191 employees
Revenue 2024
SEK 474K
+4224% vs 2023
EBITDA margin
-87.8%
+8% vs 2023
Equity ratio
0.9%
Financial strength
Net profit 2024
SEK -405K
-771% vs 2023
| Revenue | SEK 474K | +4224% |
| EBITDA | SEK -416K | +8% |
| Net profit | SEK -405K | -771% |
| Total assets | SEK 5,4M | +323% |
| Equity | SEK 46K | -95% |
| Employees | 1 | — |
Legal name
ToxoTech AB
Org number
5592341456
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
27 december 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva verksamhet inom utveckling, marknadsföring och försäljning av medicintekniska produkter, konsultverksamhet inom biomedicin och läkemedelsutveckling, samt äga, förvalta, utveckla och exploatera patent, upplåta licensrättigheter, äga och förvalta värdepapper och därmed förenlig verksamhet.
Address
Sergeantgränd 16
Email
geoffreymasuyer@hotmail.co.uk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 376 | 1 014 | 868 | 11 | 474 |
| Staff expenses | — | — | −122 | −277 | −292 |
| EBITDA | 795 | 65 | 737 | −451 | −416 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 795 | 65 | 737 | −451 | −416 |
| Net financials | — | — | 2 | 6 | 11 |
| Profit before tax | 597 | 49 | 555 | −46 | −405 |
| Tax | −128 | −11 | −115 | — | — |
| Net profit | 469 | 38 | 440 | −46 | −405 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 420 | 1 239 | 1 719 | 1 287 | 5 448 |
| Equity | 519 | 557 | 998 | 951 | 46 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 1 703 | 467 | 322 | 336 | 5 402 |
| Total debt | 1 703 | 467 | 322 | 336 | 5 402 |
EBITDA margin
-87.8%
This company
15.8%
Market median
-656% vs market
20202024
Equity ratio
0.9%
This company
38.2%
Market median
-98% vs market
20202024
Return on equity
-872.3%
This company
18.4%
Market median
-4841% vs market
20202024
Net profit margin
-85.4%
This company
8.1%
Market median
-1154% vs market
20202024
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20202024
Debt / equity
116.44×
This company
0.62×
Market median
-18681% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GC Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
DiffracTox AB | Company | 75.0% | 75.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DiffracTox AB
ToxoTech AB Board members of ToxoTech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Geoffrey Claude Maxime Masuyer | Chief Executive Officer | 0 companies |
| Lars Erik Gustav Stenmark | Deputy Board Member | 0 companies |
| Jonas Jendi | Deputy Board Member | 0 companies |
| Jonathan Jossi Ilicki | Board of Directors | 0 companies |
| Pål Erik Gustav Stenmark | Chairman | 0 companies |